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Abstract.  LEP100,  a membrane glycoprotein that has 
the unique property of shuttling  from lysosomes to en- 
dosomes to plasma membrane and back, was purified 
from chicken brain.  Its NH2-terminal amino acid se- 
quence was determined,  and an oligonucleotide encod- 
ing part of this sequence was used to clone the encod- 
ing cDNA.  The deduced amino acid sequence consists 
of 414 residues of which the NH2-terminal  18 consti- 
tute a  signal peptide. The sequence includes  17 sites 
for N-glycosylation in the NH2-terminal 75 % of the 
polypeptide chain  followed by a  region  lacking  N-linked 
oligosaccharides, a  single possible membrane-spanning 
segment, and a cytoplasmic domain of 11  residues,  in- 
cluding three potential phosphorylation sites.  Eight 
cysteine residues are spaced in a  regular pattern  through 
the lumenal  (extracellular) domain,  while a 32-residue 
sequence rich in proline,  serine,  and threonine occurs 
at its midpoint.  Expression of the cDNA in mouse L 
cells resulted in targeting of LEP100 primarily to the 
mouse lysosomes. 
S 
EVERAL lysosomal membrane glycoproteins have been 
identified  by immunological  methods,  isolated,  and 
their overall biochemical characteristics  described (1, 
6,  14, 20, 21, 27). All of these proteins  bear large numbers 
of N-linked  oligosaccharides and have apparent  molecular. 
weights (determined by SDS-PAGE) in the range  80,000 to 
120,000, whereas apparent  molecular weights  of the core 
polypeptides are in the range 40,000 to 60,000. The high level 
of glycosylation should contribute substantially  to a region 
of fixed negative charge on the lumenal  surface of the mem- 
brane and may be related  to protection of lysosomal mem- 
brane proteins from hydrolytic destruction or may have some 
as yet unknown  biological significance.  The  functions  of 
these lysosomal membrane glycoproteins are not known, but 
the functions  may include mediation  of ion permeation, ex- 
port of digestion  products, and facilitation  of the vesicular 
transport that operates to deliver materials  to the lysosome 
for digestion. 
LEPI00 resembles the other lysosomal membrane glyco- 
proteins in some general physicochemical  properties but ap- 
pears  to  be unique  in  that  it  shuttles  between lysosomes, 
endosomes, and the plasma membrane (21, 22). The distri- 
bution of LEPI00 among these membrane systems  is pro- 
foundly altered  by agents that affect lysosomal pH (22).  We 
have suggested that LEP100 may be involved in the shuttling 
process, and we have reported a remarkable congruence be- 
tween patches of this  protein on the plasma membrane of 
chloroquine-treated cells and the distribution  of membrane- 
associated clathrin  (22). Thus, we expect that some features 
of LEP100 reported here will prove to be general  for lyso- 
somal membrane glycoproteins,  whereas other features will 
relate  to functions  unique  to LEP100. 
Materials and Methods 
Maten'als 
Endoglycosidase H and l-deoxymannojirimycin were purchased from Gen- 
zyme Corp., Boston, MA. Tetremethylrhodamine-labeled goat anti-rat Ig 
was purchased from CooperBiomedical Inc., Malvern, PA.  [35S]Methio- 
nine was purchased as "Trans35S-label" from ICN Radiochemicals, Irvine, 
CA, and contained some other 3SS-labeled compounds in addition to me- 
thionine, mAb to LEP100 (LEP100-IgG) was purified and derivatized as pre- 
viously described (21). It was used as iodinated antibody or after coupling 
with fluorescein isothiocyanate (FITC-LEP100-IgG) or coupling to Sepha- 
rose 4B beads. 
Cloning of  the Encoding DNA for LEPIO0 
LEPI00 was purified from a detergent extract of chicken brain microsomes 
by immunoprecipitation with LEP100-1gG  (21) coupled to Sepharose 4B 
beads. The eluted protein was subjected to SDS-PAGE, electroeluted from 
the gel (16), and subjected to automated Edman degradation and analysis 
to determine the NH2-terminal amino acid sequence (15). The amino acid 
sequence was FDVRDSTGKVCIIANLTVAFSVEYKXXGQK, where X 
represents uncertain residues (see Results). A part of  this sequence was used 
in designing an oligonucleotide that might hybridize with LEP100 mRNA 
and cDNA. A set of 26mer oligonucleotides containing deoxyinosine at six 
positions of codon third-base ambiguity (26) were designed to bind to all 
possible encoding sequences for the amino acid sequence TGKVCIIAN: 
the  sequences were 5'-TTIGCIATIAT(A/G)CAIAC(C/T)TTICC1GT-3'. 
This set of four oligonucleotides (3:P-labeled  with polynucleotide kinase) 
was used to identify several clones (2) by screening about 300,000  plaques 
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The Journal  of Cell Biology,  Volume  106, January  1988 61-67  61 Figure  1.  Nucleotide  sequencing  strategy.  A  linear  map  of the 
cDNA  is  depicted,  with  positions  of initiation  and  termination 
codons and some common restriction enzyme sites. Horizontal ar- 
rows above the map indicate the direction and the length of each 
of the sequences read to generate the full sequence. 
from unamplified chick brain cDNA libraries (30) in kgtl0 (17). Two of 
these clones were later determined to encode the entire LEP100 protein. The 
longer of these clones is described in this report. 
DNA Sequencing 
The eDNA inserts of positive clones were subcloned into the Eco RI site 
in  the plasmids pEMBL8  and pEMBL18  (7).  DNA  sequencing by  the 
dideoxy  method  (28),  with  [35S]deoxyadenosine  5~[a-thio]triphosphate, 
established that the cDNAs exactly encoded the NH2-terminal amino acid 
sequence of LEPI00.  Further DNA sequencing was done on subcloned frag- 
ments and on fragments truncated by timed digestions with exonuclease III 
(8). We were unsuccessful in many attempts to clone the larger Eco RI frag- 
ment into the sequencing vectors pEMBL or Bluescript in an orientation 
suitable for exonuclease III deletions and sequencing from the 3' to 5' end 
of the encoding DNA.  However, we did succeed in subcloning the full- 
length eDNA into pEMBL8 and 18 in both orientations after partial Eco RI 
digestion of the original clone in lambda. Five synthetic oligonucleotides 
were used as sequencing primers to obtain the nucleotide sequence in the 
3' to 5' direction. Generally two or three sequencing runs were analyzed for 
each segment. Most of the eDNA, including the entire coding sequence, 
was determined by sequencing in both directions (Fig.  1). 
Hydrophobicity and Helicity Analyses 
For analysis of bydrophobicity and alpha-heticity, MacGene Plus software 
(Applied Genetic Technology, Fairview Park, OH) was used. These pro- 
grams employ algorithms developed by Kyte and Doolittle (19) and by Gar- 
nier et al.  (10), respectively. 
Determination of  the Number of  N-linked 
Oligosaccharide Chains 
Chicken fibroblasts were grown to confluency and then transferred to me- 
dium containing 60 ~tg/ml 1-deoxymannojirimycin (3, 9) and lacking me- 
thionine. After 2 h  [35S]methionine  (150 I.tCi/rnl) was added for 6 h. The 
biosynthetic intermediate of LEP100 with high-mannose N-linked oligosac- 
charides was isolated by immune precipitation with LEP100-IgG covalently 
linked to Sepharose 413 beads (21) and subjected to timed digestion with en- 
doglycosidase H  (31, 32).  The digested samples were analyzed by SDS- 
PAGE and fluorography, and the number of  N-linked oligosaccharide chains 
was estimated by counting the number of stepwise reductions in apparent 
molecular weight. 
Expression of  LEPIO0 cDNA in Mouse L Cells 
An expression ptasmid, pSV2CAT (12) with the restriction site 5' to the SV40 
early promotor/enhancer region changed to a Sal I site, was modified as fol- 
lows. The small Eco RI to Bam HI fragment was removed with destruction 
of the restriction sites. Then the small Hind HI to Eco RI fragment, contain- 
ing the 5' end of the CAT  gene, was removed, and the polylinker from 
M13mp8 (25) was ligated into the Hind III-Eco RI sites. The resulting shut- 
tle vector (30) was cut with Eco RI, and the large Eco RI fragment of the 
cDNA encoding LEPI00 was cloned into the Eco RI site. The orientation 
of the insert cDNA was deduced from electrophoretic analysis of Pst I re- 
striction enzyme digestion fragments. The initial expression clone used in 
the experiments reported here contained two copies of LEP100  eDNA in 
tandem. 
Mouse Ltk- cells (18) were grown in DME-MEM containing 10% FCS. 
Cells were cotransfected by the calcium phosphate precipitate method (13) 
as described by Small and Scangos (29), with 0.1 lag of  pHSVtk5'A0.2 DNA 
(24) and ,'-,1 fag of LEP100 expression plasmid DNA per 100-rran-diameter 
tissue culture plate. Cultures were switched to HAT medium (23) after 24 h 
and maintained in this medium. Clones were picked •2  wk later and main- 
mined in HAT medium. 
The number of LEPI00 molecules expressed in the transfected cells was 
estimated  by  determining the  number  of binding  sites  for  ~25I-labeled 
LEP100-IgG on fixed cells made permeable by treatment with saponin as pre- 
viously described (21). No specific binding was found unless the cells had 
been cultured in medium containing 10 mM butyrate (11) to enhance expres- 
sion offthe SV40 early promotor. (LEP100-IgG does not bind to any antigen 
in nontmnsfected mouse L cells with or without butyrate treatment.) The 
distribution of LEP100  molecules in expressing cells was visualized by 
fluorescence microscopy  after  labeling  fixed,  permeabilized  cells  with 
FITC-LEP100-IgG.  In some experiments cells were double-labeled with 
FITC-LEP100-IgG  and  mAb to  LAMPt  or  LAMP2,  mouse lysosomal 
membrane proteins (6).  For double immunofluorescence labeling, condi- 
tioned medium containing the anti-LAMP antibody was used first, followed 
by tetramethylrhodamine-labeled anti-rat IgG and FITC-LEP100-IgG. 
Results and Discussion 
Identification of  the cDNA Encoding LEPIO0 
LEP100 was purified from a detergent extract of chick brain 
microsomes  by  immune  precipitation  followed  by  SDS- 
PAGE  (see  Materials  and  Methods).  The  NH2-terminal 
amino acid sequence of LEP100,  determined by sequential 
automated Edman degradation and product analysis, was Phe- 
AspValArgAspSefrhrGlyLysValCysIleIleAlaXLeuThrValAla- 
PheSerValGluTyrLysXXGlyGlnLys.  Position 15 was deduced 
to be Asn on the basis of failure to identify any residue with 
or without reduction and alkylation of the protein before Ed- 
man degradation, and positions 26 and 27 were suspected to 
be Cys or Ser. (These predictions were confirmed by the nu- 
cleotide sequence.) With Asn assigned to position 15, the se- 
quence includes a  potential glycosylation signal  (AsnLeu- 
Thr), and the lack of a signal for Ashy5 would suggest that 
it might be completely in the N-glycosylated form. If this 
were the case, the NH2-terminal end of the molecule would 
be on the lumenal side of the lysosomal membrane. 
A  set of 26-mer oligonucleotides based on a part of the 
NH2-terminal amino acid sequence and containing deoxy- 
inosine  at  six  positions  of codon ambiguity  was  used  to 
screen an unamplified chick brain eDNA library in ~,gtl0. 
Two positive clones containing eDNA inserts of ~2.0 and 
2.2  kb  and  each containing an internal  Eco RI  site were 
found; the longer clone appeared to include all of the se- 
quence of the shorter clone.  The longer eDNA was  sub- 
cloned into the plasmids pEMBL8 and pEMBL18 (7) as full- 
length insert in both orientations and as Eco RI fragments. 
Initial  nucleotide  sequencing  by  the  dideoxy method  re- 
vealed that the larger Eco RI fragment contained the nucleo- 
tide  sequence that  encoded precisely the  amino  acid  se- 
quence determined for the NH2-terminal end of LEP100. 
Nucleotide Sequence of  the cDNA and Deduced 
Amino Acid Sequence of  LEPIO0 
The  nucleotide  sequence  of the  eDNA  and  the  deduced 
amino acid sequence of LEP100 are shown in Fig.  2.  The 
amino acid sequence begins with an 18-residue signal pep- 
tide and is followed by 396 residues, the first 30 of which ex- 
actly  match  the  NH2-terminal  amino  acid  sequence  oh- 
mined for the mature protein, confirming the identification 
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Figure 2. Nucleotide sequence and deduced amino acid sequence of a chick brain cDNA encoding LEPI00. Nucleotide residues are num- 
bered in the 5'40-3' direction: the first residue of the translation initiation triplet ATG is given the number 1, and nucleotides 5' to this 
residue are indicated by negative numbers. The sequence of only a portion of the 3' untranslated region of the cDNA is reported; the un- 
reported segment 3' to that shown in the figure is less than 100 bases long and does not contain a poly-A tail. (Genomic cloning reveals, 
in fact, that the Eco RI site at the 5' end of the cDNA is a natural site in the genomic sequence rather than due to Eco RI linker addition 
in construction of cDNA libraries [unpublished observations].) The 17 glycosylation sites are marked by triangles, cysteine residues are 
indicated by ovals, and potential phosphorylation sites by rectangles. The signal peptide is boxed, and the putative membrane-spanning 
segment is indicated by M/. 
of Asn at position  15 and Ser at positions 26 and 27.  Note 
that whereas nucleotides are numbered from the translation 
start codon, the aminoacyl residues are numbered from the 
phenylalanine that is the NH:-terminal  residue of the ma- 
ture protein. A search for homologous DNA and protein se- 
quences in the Los Alamos National Laboratory GenBank 
failed to uncover any significant homologies. 
The signal peptide displays all of the features normally as- 
sociated with leader peptides of eukaryotes (5).  There is a 
single Arg in the NH2-terminal region, a seven-amino acid 
"hydrophobic region" and the last five residues constitute a 
more hydrophilic region with Ser at positions  -3,  -2,  and 
-1,  fitting the "-3,-1  rule" 
Pattern of N-Glycosylations 
As shown in Fig.  2,  there are  17 potential N-glycosylation 
sites in the LEP100 molecule. An estimate of the actual num- 
ber of N-linked oligosaccharide chains on the LEP100 mole- 
cule  was  made  from  analysis  of the  products  of  partial 
deglycosylation by endoglycosidase H.  For this determina- 
tion, a high-mannose intermediate form of LEP100 labeled 
with  [3SS]methionine was  isolated  from  chick  fibroblasts 
and subjected to timed digestion by endoglycosidase H (see 
Materials  and Methods).  The digested  samples  were ana- 
lyzed by SDS-PAGE and fluorography, and the number of 
high-mannose  N-linked  oligosaccharide  chains  was  esti- 
mated by counting the number of stepwise reductions in ap- 
parent  molecular  weight  of the  LEP100  molecule  as  in- 
dividual oligosaccharide chains were removed (Fig. 3). The 
entire  experiment  was  done three  times.  Although at  the 
high molecular weight end of this digestion series the diges- 
tion products were never well resolved, presumably due to 
heterogeneity in the size of the high-mannose N-linked oligo- 
saccharides, nevertheless, it appears that there are approxi- 
mately  17  steps  in the series.  In the absence  of endogly- 
cosidase H digestion, the high-mannose intermediate form 
of LEP100 always appeared predominantly as a single band 
on fluorographs of SDS-PAGE, suggesting little heterogene- 
ity in total glycosylations per molecule.  These  results are 
consistent with the deduced amino acid sequence and with 
the hypothesis that each of the 17 possible sites  for N-gly- 
cosylation is indeed usually glycosylated. 
Other Features of  the Primary Structure of  LEPIO0 
In membrane and secretory proteins with multiple cysteine 
residues there are usually intrachain disulfide bridges. Eight 
cysteine residues occur in the LEP100 sequence, distributed 
in a remarkably regular pattern  in which pairs of cysteines 
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mannose  form of LEPI00  labeled  with  [35S]methionine was iso- 
lated from cultured chick fibroblasts and subjected to timed diges- 
tion with endoglycosidase H. Digestion conditions were 34 mU/ml 
endoglycosidase H in 0.1% SDS, 2% 2-mercaptoethanol,  60 mM 
sodium acetate, pH 5.8, at 37~  At intervals up to 8 h, aliquots were 
removed and incubated for 2 min in SDS sample buffer at 100~ 
to stop the enzymatic reaction. Enzyme-treated samples were ana- 
lyzed by SDS-PAGE and fluorography. In the graph,  the position 
of each discernable band in the digestion series relative to the posi- 
tion of the undigested form is plotted against band number. The 
resulting  curve is extrapolated  to the position  of the undigested 
band, yielding an estimate of N-linked oligosaccharides.  The inset 
photograph shows a fluorograph of  part of  one digestion series, with 
positions of countable bands and extrapolated positions marked. In 
this example, there is some heterogeneity in apparent mobility of 
the undigested LEPI00. 
have intrapair spacings of 38, 36, 38, and 37 residues, respec- 
tively, whereas interpair spacings are 75, 50, and 69. We sug- 
gest  that  pairs  of  adjacent  cysteine  residues  may  form 
disulfide bridges that participate in stabilization of a  set of 
four  hydrophilic  domains.  In  this  hypothetical  model  of 
higher-order  structure  the  first  three  such  domains  are 
glycosylated whereas the fourth, closest to the membrane- 
spanning segment, is unique  in lacking N-linked oligosac- 
charides. 
In the center of the amino acid sequence there is a 32-resi- 
due segment rich in Ser and Thr and containing seven proline 
residues (positions 172, t75,  183, 187, 189, 193, and  196). In 
the  helicity  plot  (10) shown  in  Fig.  4,  this  central  region 
shows a markedly low probability of containing alpha-helical 
structure.  This  central  region  of the  LEP100  polypeptide 
separates pairs of the hypothetical domains mentioned above 
and might be a  region of flexibility in the protein. 
A  hydrophobicity plot (19),  based upon calculations that 
ignore the N-linked oligosaccharides, is shown in Fig. 4. It 
seems probable that the single very hydrophobic region near 
the COOH-terminus is a membrane-spanning region. Previ- 
ously we reported evidence that LEP100 is an integral mem- 
brane protein (21). The evidence included (a) demonstration 
that  LEPI00 is a  glycoprotein that could only be isolated 
from membrane fractions by detergent extraction,  and  (b) 
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Figure 4. Alpha-helicity and hydrophobicity plots of LEP100. The 
deduced amino acid sequence of LEP100 was analyzed with Mac- 
Gene Plus software that employs the algorithms of Garnier et al. 
(10) and Kyte and Doolittle (19). Calculations were made without 
consideration  of the  numerous  N-linked  oligosaccharides.  (A) 
Alpha-helicity  plot.  (H) Hydrophobicity  plot.  In these  plots the 
probability of alpha-helical structure and the hydrophobicity indi- 
ces are plotted for the center position of  a window of 11 amino acids 
that is shifted in single amino acid steps through the sequence. Thus 
the first position that can be plotted is the sixth aminoacyl residue 
of the signal peptide  (-13  in the numbering  system that assigns 
l  to the NH2-terminal phenylalanine of the mature protein),  and 
there  is  no calculation  for the last  five residues  at the  COOH- 
terminus. 
demonstration  that  LEP100  partitions  into  the  detergent 
phase of a Triton X-114 extract. Because all of the N-glycosyl- 
ated sites surely occur on the lumenal side of the lysosomal 
membrane, any transmembrane segment within the glycosyl- 
ated NH2-terminal 75 % of the molecule would have to pass 
twice through the membrane. No such segment exists. The 
only candidate for a membrane-spanning segment is the 25- 
amino acid stretch from positions 361  to 385.  Just past this 
putative membrane-spanning segment there is a set of three 
positively charged amino acids that presumably constitute a 
"stop-transfer" sequence (4) that may serve during biosynthe- 
sis to prevent extrusion of the nascent polypeptide into the 
lumen of the endoplasmic reticulum and thenceforth to stabi- 
lize LEP100 in the lipid bilayer. Given that LEP100 is an inte- 
gral membrane protein and that hydrophobic segment 361- 
385 is the only candidate for a membrane-spanning segment, 
we  conclude  that  this  segment is  a  bona fide membrane- 
spanning one. 
There  is  a  very  short  amino  acid  sequence  from  the 
membrane-spanning segment to the COOH-terminus, con- 
stituting the cytoplasmic domain. We had expected a larger 
cytoplasmic domain for the  LEP100 molecule because we 
postulate  that  such  a  domain  might be  involved  in  mem- 
brane-cytosol  interactions  and/or  membrane-membrane 
recognition events.  The codistribution of membrane-asso- 
ciated clathrin and LEPI00 in chloroquine-treated cells (22) 
suggested the possibility that LEP100 might interact directly 
with clathrin or with some cytosolic component that links 
LEPI00 and clathrin. This possibility is not excluded by our 
findings, although we feel that the lack of a bulkier protein 
mass on the cytosolic face diminishes the likelihood of this 
possibility being correct. The cytosolic domain of LEP100 
contains  three potential phosphorylation sites:  one serine, 
one threonine, and one tyrosine. We reported previously (21) 
that we could not detect any phosphorylation of LEPI00 iso- 
lated from tissue cultured fibroblasts. In those cells •98  % 
of LEP100  molecules  occur  in  lysosomal and  endosomal 
membranes. It may be that the state of phosphorylation is 
related to the distribution of LEP100 in the cells. If this were 
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some aspects of LEP100 struc- 
ture.  Each  circle  represents 
an amino acid  in the mature 
LEPI00  molecule.  NH2- and 
COOH-terminal  ends  are in- 
dicated,  and  the  membrane- 
spanning  segment  is  repre- 
sented  as  a  projected  helix. 
The proline-rich  central  seg- 
ment is kinked to indicate its 
probable nonhelical, non-beta- 
sheet structure.  Symbols rep- 
resenting  N-linked  oligosac- 
charide chains are attached to 
the asparagine residues of the 
glycosylation signals. 
the case, then LEP100 might be detectably phosphorylated 
in chloroquine-treated cells where '~30% of LEP100 mole- 
cules are in the plasma membrane subtended by patches of 
clathrin (22). 
Fig.  5  is  a  cartoon  that  incorporates  many  features  of 
LEP100 and also some of the speculations about its higher- 
order structure mentioned previously. 
Expression of  LEPIO0 in Mouse L Cells 
The large Eco RI fragment of LEP100 cDNA was cloned into 
an expression vector derived  from pSV2CAT (12, 30) and 
cotransfected into mouse Ltk- cells together with a plasmid 
containing the herpes virus tk gene (24). No expression was 
detected  transiently,  but many tk  § clones  were isolated  in 
HAT medium. Expression of LEP100 could be activated in 
some of these clones by maintaining them in medium con- 
taining 10 mM butyrate (11). Under these conditions expres- 
sion approached maximal levels after r~48 h, at which time 
expression was comparable with that in chick fibroblasts, as 
judged by the binding of 125I-labeled LEP100-IgG to fixed, 
permeabilized cells (data not shown). 
When expressed in the mouse L cells, LEP100 is correctly 
targeted  to  lysosomes  (Fig.  6).  This  was  confirmed  by 
double-label  immunocytochemistry.  Fixed,  permeabilized 
Fambrough et al. Structure of LEPIO0  65 Figure 6.  Stable expression  of LEP100 in mouse L cells.  Mouse Ltk- cells were cotransfected with an expression  plasmid carrying the 
cDNA encoding  LEP100 together with a plasmid containing the encoding  DNA for herpes virus thymidine kinase.  Cells were selected 
in HAT medium and clones expressing  LEP100 were identified after induction of LEP100 expression  by  10 mM sodium butyrate. Cells 
growing on cover slips were fixed for 10 min with 1% formaldehyde fixative and then double-labeled  with anti-LAMP1 mAb and LEPI00- 
IgG for fluorescence microscopy as described in Materials and Methods.  Phase (A) and fluorescence  (B and C) micrographs of the same 
cell illustrate the distribution of mouse lysosomes defined by LAMP1 (B) and the distribution of LEPI00  (C).  Bar in C,  10 lam. 
cells of the transfected mouse L cell lines were labeled with 
mAb against the lysosomal membrane proteins LAMP1 and 
LAMP2 (6) followed by tetramethylrhodamine-labeled goat 
anti-rat IgG and FITC-LEP100-IgG.  Codistribution of intra- 
cellular  fluorescence from the anti-LAMP  antibodies and 
LEP100-IgG was found. Furthermore, in the presence of 100 
~tM chloroquine, LEP100 redistributed until about half of the 
molecules were in the mouse L cell plasma membrane (un- 
published observations of Paul Mathews in our laboratory). 
Thus, the expression experiments verify the identification of 
the LEP100 cDNA (based initially upon nucleotide sequence 
match-up  with  the  NH2-terminal  amino  acid  sequence  of 
LEP100)  and provide a basis for study of relationships be- 
tween LEP100 structure and its targeting to lysosomes and 
shuttling between membrane systems. 
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